{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T21:16:42Z","timestamp":1783199802185,"version":"3.54.6"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LYY19H310007"],"award-info":[{"award-number":["LYY19H310007"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.abb.2026.110857","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:28:58Z","timestamp":1778243338000},"page":"110857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Magnesium isoglycyrrhizinate ameliorates ceritinib-induced hepatotoxicity by restoring mitochondrial homeostasis"],"prefix":"10.1016","volume":"782","author":[{"given":"Zhongjiang","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0294-7399","authenticated-orcid":false,"given":"Ziye","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 3","key":"10.1016\/j.abb.2026.110857_bib1","doi-asserted-by":"crossref","first-page":"iii27","DOI":"10.1093\/annonc\/mdu199","article-title":"Metastatic non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"25","author":"Reck","year":"2014","journal-title":"Ann. Oncol."},{"issue":"11","key":"10.1016\/j.abb.2026.110857_bib2","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1080\/14737140.2023.2265566","article-title":"Treatment of advanced ALK-rearranged NSCLC following second-generation ALK-TKI failure","volume":"23","author":"Fukuda","year":"2023","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"1","key":"10.1016\/j.abb.2026.110857_bib3","article-title":"Targeted therapy for advanced anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer","volume":"1","author":"Cameron","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.abb.2026.110857_bib4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ctrv.2013.07.002","article-title":"ALK inhibitors in the treatment of advanced NSCLC","volume":"40","author":"Gridelli","year":"2014","journal-title":"Cancer Treat Rev."},{"issue":"4","key":"10.1016\/j.abb.2026.110857_bib5","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00280-020-04180-3","article-title":"Effect of ceritinib on the pharmacokinetics of coadministered CYP3A and 2C9 substrates: a phase I, multicenter, drug-drug interaction study in patients with ALK + advanced tumors","volume":"87","author":"Hurtado","year":"2021","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"6","key":"10.1016\/j.abb.2026.110857_bib6","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1158\/2159-8290.CD-13-0846","article-title":"The ALK inhibitor ceritinib overcomes crizotinib resistance in non-small cell lung cancer","volume":"4","author":"Friboulet","year":"2014","journal-title":"Cancer Discov."},{"issue":"10072","key":"10.1016\/j.abb.2026.110857_bib7","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0140-6736(17)30123-X","article-title":"First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study","volume":"389","author":"Soria","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.abb.2026.110857_bib8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-019-0105-0","article-title":"Drug-induced liver injury","volume":"5","author":"Andrade","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"6","key":"10.1016\/j.abb.2026.110857_bib9","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/hep.23937","article-title":"Drug-induced acute liver failure: results of a U.S. multicenter, prospective study","volume":"52","author":"Reuben","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.abb.2026.110857_bib10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.23736\/S2724-5985.20.02795-6","article-title":"Drug induced liver injury: from pathogenesis to liver transplantation","volume":"67","author":"Germani","year":"2021","journal-title":"Minerva Gastroenterol."},{"issue":"2","key":"10.1016\/j.abb.2026.110857_bib11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-0034-1375955","article-title":"Clinical features, diagnosis, and natural history of drug-induced liver injury","volume":"34","author":"Hayashi","year":"2014","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.abb.2026.110857_bib12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.phrs.2019.04.025","article-title":"Natural products in licorice for the therapy of liver diseases: progress and future opportunities","volume":"144","author":"Li","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.abb.2026.110857_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.785790","article-title":"Novel therapies for the treatment of drug-induced liver injury: a systematic review","volume":"12","author":"Beni\u0107","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.abb.2026.110857_bib14","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s11523-016-0460-7","article-title":"Ceritinib: a review in ALK-positive advanced NSCLC","volume":"11","author":"Deeks","year":"2016","journal-title":"Targeted Oncol."},{"issue":"1","key":"10.1016\/j.abb.2026.110857_bib15","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1186\/s12885-018-4913-5","article-title":"Possible involvement of interleukin-18 in the pathology of hepatobiliary adverse effects related to treatment with ceritinib","volume":"18","author":"Hirano","year":"2018","journal-title":"BMC Cancer"},{"issue":"Pt 1","key":"10.1016\/j.abb.2026.110857_bib16","first-page":"1","article-title":"Control of respiration and ATP synthesis in mammalian mitochondria and cells","volume":"284","author":"Brown","year":"1992","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.abb.2026.110857_bib17","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1042\/bj1910421","article-title":"Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria","volume":"191","author":"Turrens","year":"1980","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.abb.2026.110857_bib18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/jmbi.1997.1518","article-title":"Consistent structure between bacterial and mitochondrial NADH: ubiquinone oxidoreductase (complex I)","volume":"276","author":"Gu\u00e9nebaut","year":"1998","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.abb.2026.110857_bib19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.canlet.2016.03.042","article-title":"Reactive oxygen species (ROS) and cancer: role of antioxidative nutraceuticals","volume":"387","author":"Prasad","year":"2017","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.abb.2026.110857_bib20","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0981-9428(00)80093-5","article-title":"The mitochondrial respiratory chain and ATP synthase complexes: composition, structure and mutational studies","volume":"37","author":"Vedel","year":"1999","journal-title":"Plant Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.abb.2026.110857_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pupt.2005.12.007","article-title":"Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review","volume":"20","author":"Sadowska","year":"2007","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.abb.2026.110857_bib22","first-page":"145","article-title":"Personalized treatment options for ALK-positive metastatic non-small-cell lung cancer: potential role for Ceritinib","volume":"8","author":"El-Osta","year":"2015","journal-title":"Pharmgenomics Pers Med"},{"issue":"12","key":"10.1016\/j.abb.2026.110857_bib23","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1093\/jpp\/rgab125","article-title":"Magnesium isoglycyrrhizinate prevents cadmium-induced activation of JNK and apoptotic hepatocyte death by reversing ROS-inactivated PP2A","volume":"73","author":"Chen","year":"2021","journal-title":"J. Pharm. Pharmacol."},{"issue":"2","key":"10.1016\/j.abb.2026.110857_bib24","article-title":"Magnesium isoglycyrrhizinate prevented the liver injury of acetaminophen by promoting mitochondrial biogenesis","volume":"14","author":"Xia","year":"2025","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.abb.2026.110857_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173314","article-title":"Magnesium isoglycyrrhizinate alleviates fructose-induced liver oxidative stress and inflammatory injury through suppressing NOXs","volume":"883","author":"Yang","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.abb.2026.110857_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105404","article-title":"Prevention and management of idiosyncratic drug-induced liver injury: systematic review and meta-analysis of randomised clinical trials","volume":"164","author":"Niu","year":"2021","journal-title":"Pharmacol. Res."}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986126001281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986126001281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T20:59:15Z","timestamp":1783198755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986126001281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":26,"alternative-id":["S0003986126001281"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2026.110857","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Magnesium isoglycyrrhizinate ameliorates ceritinib-induced hepatotoxicity by restoring mitochondrial homeostasis","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2026.110857","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110857"}}